MARLBOROUGH, Mass.--(BUSINESS WIRE)--Acton Pharmaceuticals, Inc. (Acton), a specialty respiratory pharmaceutical company, announced today that it has completed a licensing agreement with Sanofi U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results